94 related articles for article (PubMed ID: 15498237)
1. [Active prevention and treatment of superinfection with HBV, HCV and HIV].
Zhuang H; Zhou YH
Zhonghua Yu Fang Yi Xue Za Zhi; 2004 Sep; 38(5):294-5. PubMed ID: 15498237
[No Abstract] [Full Text] [Related]
2. Treatment of hepatitis B virus infection in patients coinfected with HIV.
Benhamou Y; Bonyhay L
Gastroenterol Clin North Am; 2004 Sep; 33(3):617-27, x. PubMed ID: 15324947
[TBL] [Abstract][Full Text] [Related]
3. Antiretroviral therapy and HIV/hepatitis B virus coinfection.
Benhamou Y
Clin Infect Dis; 2004 Mar; 38 Suppl 2():S98-103. PubMed ID: 14986281
[TBL] [Abstract][Full Text] [Related]
4. Care of patients with chronic hepatitis B and HIV co-infection: recommendations from an HIV-HBV International Panel.
Soriano V; Puoti M; Bonacini M; Brook G; Cargnel A; Rockstroh J; Thio C; Benhamou Y
AIDS; 2005 Feb; 19(3):221-40. PubMed ID: 15718833
[No Abstract] [Full Text] [Related]
5. Hepatitis B virus and HIV coinfection: results of a survey on treatment practices and recommendations for therapy.
Gaglio PJ; Sterling R; Daniels E; Tedaldi E;
Clin Infect Dis; 2007 Sep; 45(5):618-23. PubMed ID: 17682998
[TBL] [Abstract][Full Text] [Related]
6. HIV and hepatitis B virus: options for managing coinfection.
Dieterich DT
Top HIV Med; 2003; 11(1):16-9. PubMed ID: 12717046
[TBL] [Abstract][Full Text] [Related]
7. Antiretroviral therapy for hepatitis B virus-HIV-coinfected patients: promises and pitfalls.
Levy V; Grant RM
Clin Infect Dis; 2006 Oct; 43(7):904-10. PubMed ID: 16941375
[TBL] [Abstract][Full Text] [Related]
8. Treatment of lamivudine-resistant hepatitis B in HIV-infected persons: is adefovir dipivoxil the answer?
Thio CL
J Hepatol; 2006 Jan; 44(1):1-3. PubMed ID: 16293338
[No Abstract] [Full Text] [Related]
9. Five-year on-treatment efficacy of lamivudine-, tenofovir- and tenofovir + emtricitabine-based HAART in HBV-HIV-coinfected patients.
Kosi L; Reiberger T; Payer BA; Grabmeier-Pfistershammer K; Strassl R; Rieger A; Peck-Radosavljevic M
J Viral Hepat; 2012 Nov; 19(11):801-10. PubMed ID: 23043387
[TBL] [Abstract][Full Text] [Related]
10. Virologic and clinical outcomes in HIV/HBV coinfected patients on tenofovir-containing HAART.
Bonacini M
Gastroenterology; 2010 Dec; 139(6):1827-9. PubMed ID: 20977876
[No Abstract] [Full Text] [Related]
11. Antiretroviral treatment change among HIV, hepatitis B virus and hepatitis C virus co-infected patients in the Australian HIV Observational Database.
Petoumenos K; Ringland C;
HIV Med; 2005 May; 6(3):155-63. PubMed ID: 15876281
[TBL] [Abstract][Full Text] [Related]
12. [The first nucleotide analog permitted. New hepatitis B therapy helps the problem patients, too].
MMW Fortschr Med; 2003 Jun; 145(24):52. PubMed ID: 12866303
[No Abstract] [Full Text] [Related]
13. Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection.
Schmutz G; Nelson M; Lutz T; Sheldon J; Bruno R; von Boemmel F; Hoffmann C; Rockstroh J; Stoehr A; Wolf E; Soriano V; Berger F; Berg T; Carlebach A; Schwarze-Zander C; Schürmann D; Jaeger H; Mauss S
AIDS; 2006 Oct; 20(15):1951-4. PubMed ID: 16988516
[TBL] [Abstract][Full Text] [Related]
14. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV-infected adults.
Rockstroh JK; Bhagani S; Benhamou Y; Bruno R; Mauss S; Peters L; Puoti M; Soriano V; Tural C;
HIV Med; 2008 Feb; 9(2):82-8. PubMed ID: 18257771
[TBL] [Abstract][Full Text] [Related]
15. Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy.
Sheng WH; Hung CC; Chang SY; Liu CJ; Chen MY; Hsieh SM; Kao JH; Chen PJ; Chang SC
Clin Infect Dis; 2012 Feb; 54(4):548-55. PubMed ID: 22156858
[TBL] [Abstract][Full Text] [Related]
16. [Treating chronic lamivudine-resistant hepatitis B in HIV co-infected patients].
Benhamou Y
Gastroenterol Clin Biol; 2006 Oct; 30(10 Pt 2):3S22-5. PubMed ID: 17075492
[No Abstract] [Full Text] [Related]
17. [Impact of HIV on HCV, GBV-C/HGV, and HBV infection].
Hayashi K; Toyoda H; Nakano I; Fukuda Y; Takamatsu J
Nihon Rinsho; 2002 Apr; 60(4):798-802. PubMed ID: 11968791
[TBL] [Abstract][Full Text] [Related]
18. Haemolytic anaemia after nucleotide antiretroviral treatment discontinuation in a chronic hepatitis B-virus co-infected AIDS patient.
Stephan C; Brodt HR; Berger A; Lutz T; Mösch M; Lennemann TS; Stürmer M; Staszewski S
AIDS; 2004 Jul; 18(11):1613-4. PubMed ID: 15238788
[No Abstract] [Full Text] [Related]
19. Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir.
Mikulska M; Taramasso L; Giacobbe DR; Caligiuri P; Bruzzone B; Di Biagio A; Viscoli C
J Med Virol; 2012 Sep; 84(9):1340-3. PubMed ID: 22825811
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic interventions for HIV infection and chronic viral hepatitis.
Cooper CL
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S69-72. PubMed ID: 16265617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
